CHRS Coherus Biosciences Inc

Coherus BioSciences Inc is a biotechnology company that develops biosimilar therapeutics. The company seeks to ensure successful drug development and manufacturing under very aggressive timelines.

$9.36  -0.26 (-2.65%)
As of 10/03/2022 15:59:52 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/06/2014
Outstanding shares:  77,724,589
Average volume:  1,145,186
Market cap:   $726,724,907
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BRK0149
Valuation   (See tab for details)
PE ratio:   -3.55
PB ratio:   59.32
PS ratio:   2.39
Return on equity:   -1,673.46%
Net income %:   -69.24%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy